Abstract
Purpose
Radon is a risk factor for lung cancer and uranium miners are more exposed than the general population. A genome-wide interaction analysis was carried out to identify genomic loci, genes or gene sets that modify the susceptibility to lung cancer given occupational exposure to the radioactive gas radon.
Methods
Samples from 28 studies provided by the International Lung Cancer Consortium were pooled with samples of former uranium miners collected by the German Federal Office of Radiation Protection. In total, 15,077 cases and 13,522 controls, all of European ancestries, comprising 463 uranium miners were compared. The DNA of all participants was genotyped with the OncoArray. We fitted single-marker and in multi-marker models and performed an exploratory gene-set analysis to detect cumulative enrichment of significance in sets of genes.
Results
We discovered a genome-wide significant interaction of the marker rs12440014 within the gene CHRNB4 (OR = 0.26, 95% CI 0.11–0.60, p = 0.0386 corrected for multiple testing). At least suggestive significant interaction of linkage disequilibrium blocks was observed at the chromosomal regions 18q21.23 (p = 1.2 × 10−6), 5q23.2 (p = 2.5 × 10−6), 1q21.3 (p = 3.2 × 10−6), 10p13 (p = 1.3 × 10−5) and 12p12.1 (p = 7.1 × 10−5). Genes belonging to the Gene Ontology term “DNA dealkylation involved in DNA repair” (GO:0006307; p = 0.0139) or the gene family HGNC:476 “microRNAs” (p = 0.0159) were enriched with LD-blockwise significance.
Conclusion
The well-established association of the genomic region 15q25 to lung cancer might be influenced by exposure to radon among uranium miners. Furthermore, lung cancer susceptibility is related to the functional capability of DNA damage signaling via ubiquitination processes and repair of radiation-induced double-strand breaks by the single-strand annealing mechanism.
Similar content being viewed by others
References
Alexander DH, Novembre J, Lange K (2009) Fast model-based estimation of ancestry in unrelated individuals. Genome Res 19(9):1655–1664. https://doi.org/10.1101/gr.094052.109
Amos CI et al (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40(5):616–622
Amos CI et al (2017) The OncoArray Consortium: a network for understanding the genetic architecture of common cancers. Cancer Epidemiol Biomark Prev 26(1):126–135. https://doi.org/10.1158/1055-9965.EPI-16-0106
Ashburner M et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1):25–29
Baias PF, Hofmann W, Winkler-Heil R, Cosma C, Duliu OG (2010) Lung dosimetry for inhaled radon progeny in smokers. Radiat Prot Dosim 138(2):111–118. https://doi.org/10.1093/rpd/ncp183
Bhatlekar S, Fields JZ, Boman BM (2014) HOX genes and their role in the development of human cancers. J Mol Med 92(8):811–823. https://doi.org/10.1007/s00109-014-1181-y
Bosse Y, Amos CI (2017) A decade of GWAS results in lung cancer. Cancer Epidemiol Biomark Prev. https://doi.org/10.1158/1055-9965.EPI-16-0794
Brennan P, Hainaut P, Boffetta P (2011) Genetics of lung-cancer susceptibility. Lancet Oncol 12(4):399–408. https://doi.org/10.1016/s1470-2045(10)70126-1
Brüske-Hohlfeld I et al (2006) Lung cancer risk among former uranium miners of the WISMUT Company in Germany. Health Phys 90(3):208–216. https://doi.org/10.1097/01.HP.0000175443.08832.84
Chen HJ et al (2015a) Contribution of genotype of DNA double-strand break repair gene XRCC3, gender, and smoking behavior to lung cancer risk in Taiwan. Anticancer Res 35(7):3893–3899
Chen LS et al (2015b) CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis—a meta-analysis. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djv100
Ciccia A, Elledge SJ (2010) The DNA damage response: making it safe to play with knives. Mol cell 40(2):179–204. https://doi.org/10.1016/j.molcel.2010.09.019
Cunningham F et al (2015) Ensembl 2015. Nucleic Acids Res 43(Database issue):D662–D669. https://doi.org/10.1093/nar/gku1010
Darby S et al (2005) Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case–control studies. BMJ 330(7485):223
Dexheimer TS (2013) DNA repair pathways and mechanisms. In: Mathews LA, Cabarcas SM, Hurt EM (eds) DNA repair of cancer stem cells. Springer Netherlands, Dordrecht, pp 19–32
Falvella FS et al (2009) Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk. Clin Cancer Res Off J Am Assoc Cancer Res 15(5):1837–1842. https://doi.org/10.1158/1078-0432.CCR-08-2107
Gray KA, Yates B, Seal RL, Wright MW, Bruford EA (2015) Genenames.org: the HGNC resources in 2015. Nucleic Acids Res 43(Database issue):D1079–D1085. https://doi.org/10.1093/nar/gku1071
Grosche B, Kreuzer M, Kreisheimer M, Schnelzer M, Tschense A (2006) Lung cancer risk among German male uranium miners: a cohort study, 1946–1998. Br J Cancer 95(9):1280–1287. https://doi.org/10.1038/sj.bjc.6603403
Guo Y, An L, Ng HM, Sy SM, Huen MS (2017) An E2-guided E3 screen identifies the RNF17–UBE2U pair as regulator of the radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties (RIDDLE) syndrome protein RNF168. J Biol Chem 292(3):967–978. https://doi.org/10.1074/jbc.M116.758854
Huckins LM et al (2014) Using ancestry-informative markers to identify fine structure across 15 populations of European origin. Eur J Hum Genet EJHG 22(10):1190–1200. https://doi.org/10.1038/ejhg.2014.1
Ishida M et al (2014) Smoking cessation reverses DNA double-strand breaks in human mononuclear cells. PLoS One 9(8):e103993. https://doi.org/10.1371/journal.pone.0103993
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Kazma R et al (2012) Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium. Carcinogenesis 33(5):1059–1064. https://doi.org/10.1093/carcin/bgs116
Kosoy R et al (2009) Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 30(1):69–78. https://doi.org/10.1002/humu.20822
Kreuzer M, Grosche B, Schnelzer M, Tschense A, Dufey F, Walsh L (2010a) Radon and risk of death from cancer and cardiovascular diseases in the German uranium miners cohort study: follow-up 1946–2003. Radiat Environ Biophys 49(2):177–185. https://doi.org/10.1007/s00411-009-0249-5
Kreuzer M, Schnelzer M, Tschense A, Walsh L, Grosche B (2010b) Cohort profile: the German uranium miners cohort study (WISMUT cohort), 1946–2003. Int J Epidemiol 39(4):980–987. https://doi.org/10.1093/ije/dyp216
Kreuzer M, Fenske N, Schnelzer M, Walsh L (2015) Lung cancer risk at low radon exposure rates in German uranium miners. Br J Cancer 113(9):1367–1369. https://doi.org/10.1038/bjc.2015.324
Leng S et al (2013) Genetic variation in SIRT1 affects susceptibility of lung squamous cell carcinomas in former uranium miners from the Colorado plateau. Carcinogenesis 34(5):1044–1050. https://doi.org/10.1093/carcin/bgt024
Leng S et al (2016) Radon exposure, IL-6 promoter variants, and lung squamous cell carcinoma in former uranium miners. Environ Health Perspect 124(4):445–451. https://doi.org/10.1289/ehp.1409437
Leuraud K et al (2011) Radon, smoking and lung cancer risk: results of a joint analysis of three European case–control studies among uranium miners. Radiat Res 176(3):375–387
Liu P et al (2008) Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 100(18):1326–1330. https://doi.org/10.1093/jnci/djn268
Liu Y et al (2009) Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. Cancer Res 69(19):7844–7850. https://doi.org/10.1158/0008-5472.CAN-09-1833
McColl N et al (2015) European code against cancer 4th edition: Ionising and non-ionising radiation and cancer. Cancer Epidemiol 39(Suppl 1):S93–S100. https://doi.org/10.1016/j.canep.2015.03.016
McKay JD et al (2017) Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet 49(7):1126–1132. https://doi.org/10.1038/ng.3892
Mukherjee B, Ahn J, Gruber SB, Rennert G, Moreno V, Chatterjee N (2008) Tests for gene–environment interaction from case–control data: a novel study of type I error, power and designs. Genet Epidemiol 32(7):615–626. https://doi.org/10.1002/gepi.20337
Murcray CE, Lewinger JP, Conti DV, Thomas DC, Gauderman WJ (2011) Sample size requirements to detect gene–environment interactions in genome-wide association studies. Genet Epidemiol 35(3):201–210. https://doi.org/10.1002/gepi.20569
National Research Council (1999) Health effects of exposure to radon. BEIR VI, Washington (DC)
Papke RL (2014) Merging old and new perspectives on nicotinic acetylcholine receptors. Biochem Pharmacol 89(1):1–11. https://doi.org/10.1016/j.bcp.2014.01.029
Pesch B, Johnen G, Lehnert M (2015) Aufbau einer Bioproben-Bank von ehemaligen Beschäftigten der SAG/SDAG Wismut—Pilotstudie. Ressortforschungsberichte zur kerntechnischen Sicherheit und zum Strahlenschutz. BfS-Bundesamt für Strahlenschutz. https://doris.bfs.de/jspui/handle/urn:nbn:de:0221-2015102213745. Accessed 29 Jun 2017
Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003) Studies of mortality of atomic bomb survivors. Report 13 Solid cancer and noncancer disease mortality: 1950–1997. Radiat Res 160(4):381–407
Purcell S et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575. https://doi.org/10.1086/519795
Ridge CA, McErlean AM, Ginsberg MS (2013) Epidemiology of lung cancer. Semin Interv Radiol 30(2):93–98. https://doi.org/10.1055/s-0033-1342949
Robertson A, Allen J, Laney R, Curnow A (2013) The cellular and molecular carcinogenic effects of radon exposure: a review. Int J Mol Sci 14(7):14024–14063. https://doi.org/10.3390/ijms140714024
Romero-Laorden N, Castro E (2017) Inherited mutations in DNA repair genes and cancer risk. Curr Probl Cancer 41(4):251–264. https://doi.org/10.1016/j.currproblcancer.2017.02.009
Rosenberger A et al (2012) Heritability of radiation response in lung cancer families. Genes 3(2):248–260. https://doi.org/10.3390/genes3020248
Ruano-Ravina A, Pereyra MF, Castro MT, Perez-Rios M, Abal-Arca J, Barros-Dios JM (2014) Genetic susceptibility, residential radon, and lung cancer in a radon prone area. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 9(8):1073–1080. https://doi.org/10.1097/JTO.0000000000000205
Sakoda LC et al (2011) Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Cancer Causes Control 22(3):449–461. https://doi.org/10.1007/s10552-010-9716-1
Schnelzer M, Hammer GP, Kreuzer M, Tschense A, Grosche B (2010) Accounting for smoking in the radon-related lung cancer risk among German uranium miners: results of a nested case–control study. Health Phys 98(1):20–28. https://doi.org/10.1097/HP.0b013e3181b8ce81
Schubauer-Berigan MK, Daniels RD, Pinkerton LE (2009) Radon exposure and mortality among white and American Indian uranium miners: an update of the Colorado Plateau cohort. Am J Epidemiol 169(6):718–730. https://doi.org/10.1093/aje/kwn406
Sethi TK, El-Ghamry MN, Kloecker GH (2012) Radon and lung cancer. Clin Adv Hematol Oncol 10(3):157–164
Setsirichok D et al (2012) Small Ancestry Informative Marker panels for complete classification between the original four HapMap populations. Int J Data Min Bioinform 6(6):651–674
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30. https://doi.org/10.3322/caac.21332
Stenzel SL, Ahn J, Boonstra PS, Gruber SB, Mukherjee B (2015) The impact of exposure-biased sampling designs on detection of gene–environment interactions in case–control studies with potential exposure misclassification. Eur J Epidemiol 30(5):413–423. https://doi.org/10.1007/s10654-014-9908-1
Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545–15550
Torre LA, Siegel RL, Jemal A (2016) Lung cancer statistics. Adv Exp Med Biol 893:1–19. https://doi.org/10.1007/978-3-319-24223-1_1
Vahakangas KH et al (1992) Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339(8793):576–580
van Wijk SJ, Timmers HT (2010) The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J Off Publ Fed Am Soc Exp Biol 24(4):981–993. https://doi.org/10.1096/fj.09-136259
Walsh L, Tschense A, Schnelzer M, Dufey F, Grosche B, Kreuzer M (2010) The influence of radon exposures on lung cancer mortality in German uranium miners, 1946–2003. Radiat Res 173(1):79–90. https://doi.org/10.1667/RR1803.1
Ward JF (1988) DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol 35:95–125
Yang J et al (2011) Genomic inflation factors under polygenic inheritance. Eur J Hum Genet EJHG 19(7):807–812. https://doi.org/10.1038/ejhg.2011.39
Yngveson A, Williams C, Hjerpe A, Lundeberg J, Soderkvist P, Pershagen G (1999) p53 Mutations in lung cancer associated with residential radon exposure. Cancer Epidemiol Biomark Prev 8(5):433–438
Funding
This investigation, and the data sources used, were funded by following bodies: Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (Bundesministerium für Umwelt, Naturschutz und Reaktorsicherheit, BMU) (3608S04532 to G. Johnen and B. Pesch for sample collection of the German Uranium Miners Bio- and Databank (GUMB), 3614S10013, 3614S10014, 3615S32253 to H. Bickeböller for planning, genotyping, quality control and analysis of this project). National Institutes of Health (U19-CA148127, CA148127S1, 1U19CA148127-02 to Transdisciplinary Research for Cancer in Lung). Cancer Care Ontario Research (to R. J. Hung for ILCCO data harmonization). FIS-FEDER/Spain (FIS-01/310, FIS-PI03- 0365, FIS-07-BI060604 for the CAPUA study). FICYT/Asturias (FICYT PB02-67 and FICYT IB09-133 for the CAPUA study). National Institute of Health/National Cancer Institute (UM1 CA167462 to G. E. Goodman for the CARET study). National Institute of Health R01 (CA111703 to C. Chen, 5R01 CA151989-01A1 to J. A. Doherty, both for the CARET study). Roy Castle Lung Cancer Foundation (for the Liverpool Lung project). National Cancer Institute (CA092824, CA090578, CA074386; for the Harvard Lung Cancer Study). Canadian Cancer Society Research Institute (020214 for the MSH-PMH study). Ontario Institute of Cancer and Cancer Care Ontario Chair Award (to R. J. Hung and G. Liu for the MSH-PMH study). Alan Brown Chair and Lusi Wong Programs at the Princess Margaret Hospital Foundation (for the MSH-PMH study). Norwegian Cancer Society/Norwegian Research Council (for the Norway study). James and Esther King Biomedical Research Program (09KN-15, for the TLC study). National Institutes of Health Specialized Programs of Research Excellence (SPORE) Grant (P50 CA119997, for the TLC study). Cancer Center Support Grant (CCSG) at the H. Lee Moffitt Cancer Center and Research Institute (P30-CA76292, for the TLC study). Vanderbilt University Medical Center’s BioVU (1S10RR025141-01, for the Vanderbilt Lung Cancer Study). National Center for Advancing Translational Sciences (UL1TR000445 for the Vanderbilt Lung Cancer Study). National Cancer Institute (K07CA172294 to Aldrich for the Vanderbilt Lung Cancer Study). National Genome Research Institute (U01HG004798, to Crawford for the Vanderbilt Lung Cancer Study). Chief Physician Johan Boserup and Lise Boserup Fund/Danish Medical Research Council and Herlev Hospital (for the Copenhagen General Population Study). National Center for Research Resources (P20RR018787 for the NELCS study). Department of Defense/Congressionally Directed Medical Research Program, US Army Medical Research and Materiel Command Program 10153006 (W81XWH-11-1-0781 for NELCS study within the Kentucky Lung Cancer Research Initiative). International Agency for Research on Cancer (for coordination the IARC L2 study). National Institutes of Health (R01-DE12206, P01-CA68384, R01-DE13158 for the Tampa Lung Cancer Study). Terry Fox Research Institute and the Canadian Partnership Against Cancer (for the Pan-Canadian Early Detection of Lung Cancer Study).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The sampling of blood from the Wismut miners was approved by the Bavarian Medical Association (Bayerische Landesärztekammer) #08082 and the German Federal Commissioner for data protection and freedom of information. This research received approval from the Dartmouth Committee for Protection of Human Subjects on 7/30/2014 with id STUDY00023602.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
420_2018_1334_MOESM1_ESM.docx
Supplementary materials and methods, supplementary figures I–III, supplementary tables I–IV and further discussion of the gene–radon interaction at 10p13 and 12p12.1 can be found at Online Resource 1 (DOCX 926 KB)
Rights and permissions
About this article
Cite this article
Rosenberger, A., Hung, R.J., Christiani, D.C. et al. Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health 91, 937–950 (2018). https://doi.org/10.1007/s00420-018-1334-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00420-018-1334-3